Smith-Magenis Syndrome
Also known as: Smith-Magenis Syndrome (SMS) / Smith Magenis Syndrome / Other microdeletions / Smith-Magenis syndrome (disorder)
Drug | Drug Name | Drug Description |
---|---|---|
DB09071 | Tasimelteon | A melatonin receptor agonist used to treat Non- 24-Hour Sleep-Wake Disorder. |
Drug | Drug Name | Target | Type |
---|---|---|---|
DB09071 | Tasimelteon | Melatonin receptor type 1A | target |
DB09071 | Tasimelteon | Melatonin receptor type 1B | target |
DB09071 | Tasimelteon | Cytochrome P450 3A4 | enzyme |
DB09071 | Tasimelteon | Cytochrome P450 1A2 | enzyme |
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB09071 | Tasimelteon | 1 | Completed | 1 |
DB09071 | Tasimelteon | 2 / 3 | Completed | 1 |
DB11895 | Lenomorelin | Not Available | Recruiting | 1 |
DB01065 | Melatonin | Not Available | Completed | 1 |